Technical Analysis for RPTX - Repare Therapeutics Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical RPTX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | -1.63% | |
| Slingshot Bearish | Bearish Swing Setup | -1.63% | |
| Lower Bollinger Band Walk | Weakness | -1.63% | |
| Lower Bollinger Band Walk | Weakness | -1.08% | |
| Lower Bollinger Band Touch | Weakness | -1.08% | |
| Oversold Stochastic | Weakness | -1.08% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.73% | |
| Stochastic Buy Signal | Bullish | -2.73% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 1.5x Volume Pace | about 5 hours ago | |
| Down 5% | about 5 hours ago | |
| Fell Below Lower Bollinger Band | about 5 hours ago | |
| Down 3% | about 6 hours ago | |
| Lower Bollinger Band Support | about 6 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Repare Therapeutics is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Genetics Precision Medicine Cancer Therapies Genome CRISPR Synthetic Lethality
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Genetics Precision Medicine Cancer Therapies Genome CRISPR Synthetic Lethality
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 46.44 |
| 52 Week Low | 21.45 |
| Average Volume | 144,708 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 36.38 |
| 20-Day Moving Average | 34.93 |
| 10-Day Moving Average | 33.12 |
| Average True Range | 2.58 |
| ADX | 14.71 |
| +DI | 16.63 |
| -DI | 22.28 |
| Chandelier Exit (Long, 3 ATRs ) | 32.23 |
| Chandelier Exit (Short, 3 ATRs ) | 37.79 |
| Upper Bollinger Band | 38.92 |
| Lower Bollinger Band | 30.94 |
| Percent B (%b) | 0.14 |
| BandWidth | 22.83 |
| MACD Line | -1.32 |
| MACD Signal Line | -0.98 |
| MACD Histogram | -0.3402 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 36.43 | ||||
| Resistance 3 (R3) | 36.49 | 35.09 | 35.71 | ||
| Resistance 2 (R2) | 35.09 | 33.99 | 35.07 | 35.46 | |
| Resistance 1 (R1) | 33.59 | 33.30 | 32.89 | 33.53 | 35.22 |
| Pivot Point | 32.19 | 32.19 | 31.85 | 32.17 | 32.19 |
| Support 1 (S1) | 30.69 | 31.09 | 29.99 | 30.63 | 28.94 |
| Support 2 (S2) | 29.29 | 30.40 | 29.27 | 28.70 | |
| Support 3 (S3) | 27.79 | 29.29 | 28.46 | ||
| Support 4 (S4) | 27.73 |
